Skip to main content

Advertisement

SpringerLink
Log in

Fructo-oligosaccharide Reduces Inflammation in a Dextran Sodium Sulphate Mouse Model of Colitis

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Fructo-oligosaccharide (FOS) is a prebiotic that stimulates the colonic growth of bifidobacteria to promote intestinal health. This study assessed whether FOS can reduce intestinal damage associated with ulcerative colitis and accelerate recovery in a mouse model. C57BL/6 mice received 2% dextran sulphate sodium for 7 days (days 8–14). FOS (1.5 g/mL) treatment was administered twice daily (n=10/group): before and during colitis (days 1–14); during colitis (days 10–14); and during colitis and the recovery period (days 10–19). Disease activity was scored daily and colonic damage was assessed by histological analysis. FOS treatment significantly reduced disease activity and damage in the distal colon (P < .05). Treatment with FOS (days 10–14) had increased crypt depth (116±6 μm) compared to water treatment (90±4 μm, P < .05). FOS treatment (days 10–19) produced a faster recovery from damage with increased crypt depth and crypt area. These results demonstrate the protective effect of FOS treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Rutgeerts P (2002) A critical assessment of new therapies in inflammatory bowel disease. J Gastroenterol Hepatol 17:176–185

    Article  Google Scholar 

  2. Ardizzone S, Bianchi Porro G (2002) Inflammatory bowel disease: new insights into pathogenesis and treatment. J Int Med 252:475–496

    Article  CAS  Google Scholar 

  3. Gaudio E, Taddei G, Vetuschi A, Sferra R, Frieri G, Ricciardi G, Caprilli R (1999) Dextran sulfate sodium (DSS) colitis in rats. Dig Dis Sci 44:1458–1475

    Article  PubMed  CAS  Google Scholar 

  4. Carter M, Lobo A, Travis S (2004) Guidelines for the management of inflammatory bowel disease in adults. Gut 53:v1–v16

    Article  PubMed  Google Scholar 

  5. Farrell R, Peppercorn M (2002) Ulcerative colitis. Lancet 359:331–340

    Article  PubMed  Google Scholar 

  6. Vowinkel T, Kalogeris T, Mori M, Krieglstein C, Granger N (2004) Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis. Dig Dis Sci 49:556–564

    Article  PubMed  CAS  Google Scholar 

  7. Cherbut C, Michel C, Lecannu G (2003) The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. J Nutr 133:21–27

    PubMed  CAS  Google Scholar 

  8. Videla S, Vilaseca J, Antolin M, Garcia-Lafuente A, Guarner F, Crespo E, Casalots J, Salas A, Malagelada J (2001) Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat. Am J Gastroenterol 96:1486–1493

    Article  PubMed  CAS  Google Scholar 

  9. Gibson G, Roberfroid M (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125:1401–1412

    PubMed  CAS  Google Scholar 

  10. Mitsuoka T, Hidaka H, Eida T (1987) Effect of fructo-oligosaccharides on intestinal microflora. Die Nahrung 31:427–436

    Article  PubMed  CAS  Google Scholar 

  11. Reddy B (1999) Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumour growth. J Nutr 129:1478S–1482S

    PubMed  CAS  Google Scholar 

  12. Bornet F, Brouns F (2002) Immune-stimulating and gut health-promoting properties of short-chain fructo-oligosaccharides. Nutr Rev 60:326–334

    Article  PubMed  Google Scholar 

  13. Le Blay G, Michel C, Blottiere H, Cherbut C (1999) Prolonged intake of fructo-oligosaccharides induces a short-term elevation of lactic acid-producing bacteria and a persistent increase in caecal butyrate in rats. J Nutr 129:2231–2235

    PubMed  CAS  Google Scholar 

  14. Marteau P, Boutron-Ruault C (2002) Nutritional advantages of probiotics and prebiotics. Br J Nutr 87:S153–S157

    PubMed  CAS  Google Scholar 

  15. Probert H, Gibson G (2002) Investigating the prebiotic and gas-generating effects of selected carbohydrates on the human colonic microflora. Lett Appl Microbiol 35:473–480

    Article  PubMed  CAS  Google Scholar 

  16. Ohta A, Baba S, Ohtsuki M, Taguchi A, Adachi T (1996) Prevention of coprophagy modifies magnesium absorption in rats fed with fructo-oligosaccharides. Br J Nutr 75:775–784

    Article  PubMed  CAS  Google Scholar 

  17. Tahiri M, Tressol J, Arnaud J, Bornet F, Bouteloup-Demange C, Feillet-Coudray C, Ducros V, Pepin D, Brouns F, Rayssiguier A, Coudray C (2001) Five-week intake of short-chain fructo-oligosaccharides increases intestinal absorption and status of magnesium in postmenopausal women. J Bone Miner Res 16:2152–2160

    Article  PubMed  CAS  Google Scholar 

  18. Gibson G, Beatty E, Wang X, Cummings J (1995) Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108:975–982

    Article  PubMed  CAS  Google Scholar 

  19. Kaur N, Gupta A (2002) Applications of inulin and oligofructose in health and nutrition. J Biosci 27:703–714

    Article  PubMed  CAS  Google Scholar 

  20. Axelsson L, Landstrom E, Bylund-Fellenius A (1998) Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine. Aliment Pharmacol Ther 12:925–934

    Article  PubMed  CAS  Google Scholar 

  21. Kullman F, Messmann H, Alt M, Gross V, Bocker T, Scholmerich J, Ruschoff J (2001) Clinical and histopathological features of dextran sulfate sodium induced acute and chronic colitis associated with dysplasia in rats. In J Colorectal Dis 16:238–246

    Article  Google Scholar 

  22. Kitajima S, Takuma S, Morimoto M (1999) Tissue distribution of dextran sulfate sodium (DSS) in the acute phase of murine DSS-induced colitis. J Vet Med Sci 61:67–70

    Article  PubMed  CAS  Google Scholar 

  23. Egger B, Bajaj-Elliott M, MacDonald T, Inglin R, Eysselein V, Buchler M (2000) Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 62:240–248

    Article  PubMed  CAS  Google Scholar 

  24. Ahmad M, Krishnan S, Ramakrishna B, Mathan M, Pulimood A, Murthy S (2000) Butyrate and glucose metabolism by colonocytes in experimental colitis in mice. Gut 46:493–499

    Article  PubMed  CAS  Google Scholar 

  25. Howarth G, Xian C, Read L (2000) Predisposition to colonic dysplasia is unaffected by continuous administration of insulin-like growth factor-I for twenty weeks in a rat model of inflammatory bowel disease. Growth Factors 18:119–133

    Article  PubMed  CAS  Google Scholar 

  26. Murthy S, Cooper H, Shim H, Shah R, Ibrahim S, Sedergran D (1993) Treatment of dextran sulfate sodium- induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 38:1722–1734

    Article  PubMed  CAS  Google Scholar 

  27. Kolida S, Tuohy K, Gibson G (2002) Prebiotic effects of inulin and oligofructose. Br J Nutr 87:S193–S197

    Article  PubMed  CAS  Google Scholar 

  28. Langlands S, Hopkins M, Coleman N, Cummings J (2004) Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 53:1610–1616

    Article  PubMed  CAS  Google Scholar 

  29. Rycroft C, Jones M, Gibson G, Rastall R (2001) A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 91:878–887

    Article  PubMed  CAS  Google Scholar 

  30. Bouhnik Y, Vahedi K, Achour L, Attar A, Salfati J, Pochart P, Marteau P, Flourie B, Bornet F, Rambaud J (1999) Short-Chain Fructo-oligosaccharide administration dose-dependently increases faecal bifidobacteria. J Nutr 129:113–116

    PubMed  CAS  Google Scholar 

  31. Gibson G, Wang X (1994) Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 77:412–420

    PubMed  CAS  Google Scholar 

  32. Campbell J, Fahey G, Wolf B (1997) Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal shortchain fatty acids, pH and microflora in rats. J Nutr 127:130–136

    PubMed  CAS  Google Scholar 

  33. Nadeau D (2000) Intestinal warfare: the role of short-chain fructo-oligosaccharides in health and disease. Nutr Clin Care 3:266–273

    Article  Google Scholar 

  34. Chapman M, Grahn M, Boyle M, Hutton M, Rogers J, Williams N (1994) Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 35:73–76

    Article  PubMed  CAS  Google Scholar 

  35. Tuohy K, Probert H, Smejkal C, Gibson G (2003) Using probiotics and prebiotics to improve gut health. Drug Discovery Today 8:692–700

    Article  PubMed  Google Scholar 

  36. Fujiwara M, Kaneko T, Iwana H, Taketomo N, Tsunoo H, Kanno J, Ohkusa T, Okayasu I (2003) Inhibitory effects of Bifidobacterium longum on experimental ulcerative colitis induced in mice by synthetic dextran sulfate sodium. Digestion 67:90–95

    Article  PubMed  Google Scholar 

  37. Campbell M, Kolev Y, Hendrich T, Stahl B, Boehm G, Stevenson L, Butler R (2004) The role of oligosaccharides and Helicobacter pylori-specific antibodies in prevention of gastritis. Helicobacter 9:518–525

    Article  Google Scholar 

  38. Rumi G, Tsubouchi R, Okayama M, Kato S, Mozsik G, Takeuchi K (2004) Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats. Dig Dis Sci 49:1466–1472

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Paediatric and Adolescent Gastroenterology, Women’s and Children’s Hospital, 72 King William Road, North Adelaide, South Australia, 5006, Australia

    Jessica Winkler, Ross Butler & Erin Symonds

  2. Discipline of Physiology, School of Molecular and Biomedical Sciences, The University of Adelaide, Adelaide, South Australia, Australia

    Jessica Winkler & Ross Butler

Authors
  1. Jessica Winkler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ross Butler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Erin Symonds
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jessica Winkler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Winkler, J., Butler, R. & Symonds, E. Fructo-oligosaccharide Reduces Inflammation in a Dextran Sodium Sulphate Mouse Model of Colitis. Dig Dis Sci 52, 52–58 (2007). https://doi.org/10.1007/s10620-006-9224-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9224-z

Keywords

Search

Navigation